Search
for
Sort by
Research 151–180 of 242
- The JAK/STAT signaling pathway: from bench to clinic
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Cutting Edge: Memory Regulatory T Cells Require IL-7 and Not IL-2 for Their Maintenance in Peripheral Tissues
- COVID-19: Pulmonary and Extra Pulmonary Manifestations
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- BAC-mediated gene-dosage analysis reveals a role for Zipro1 (Ru49/Zfp38) in progenitor cell proliferation in cerebellum and skin
- Long-Term Effects of COVID-19
- Genetic Ablation of the <i>CDP/Cux</i> Protein C Terminus Results in Hair Cycle Defects and Reduced Male Fertility
- Immunosuppressive treatment for proliferative lupus nephritis
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program
- Clinical and immunological manifestations in 151 SLE patients living in Dubai
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Hair Defects and Pup Loss in Mice with Targeted Deletion of the First Cut Repeat Domain of theCux/CDPHomeoprotein Gene
- Treatment of pediatric alopecia areata: A systematic review
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Lipid-Based Drug Delivery Systems in Regenerative Medicine
- Sarcoidosis: Are there differences in your skin of color patients?
- FOXN1 deficient nude severe combined immunodeficiency
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Commonalities Between COVID-19 and Radiation Injury
- Systemic Lupus Erythematosus With Acute Inflammatory Demyelinating Polyneuropathy: A Case Report and Review of the Literature
- Identification of an Intronic Regulatory Element Necessary for Tissue-Specific Expression of <i>Foxn1</i> in Thymic Epithelial Cells
- Clinical Features of Systemic Lupus Erythematosus Patients Complicated With Evans Syndrome
- Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus
- Cell-Free Therapies: The Use of Cell Extracts to Mitigate Irradiation-Injured Salivary Glands